XML 36 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-based Compensation Expense for Employees and Non-employees

In the accompanying condensed consolidated statements of operations, the Company recognized stock-based compensation expense for its employees and non-employees as follows:

 

     Three Months Ended
March 31,
 
     2017      2016  
     (in thousands)  

Research and development

   $ 1,013      $ 954  

General and administrative

     514        409  
  

 

 

    

 

 

 

Total stock-based compensation

   $ 1,527      $ 1,363  
  

 

 

    

 

 

 

Schedule of Estimated Grant-date Fair Values of Stock-based Awards Using Black-Scholes Option Pricing Model Assumptions

The estimated grant-date fair values of all of the Company’s stock-based awards were calculated using the Black-Scholes option pricing model, based on assumptions as follows:

 

     Three Months Ended
March 31,
 
     2017     2016  

Expected term (in years)

     5.4 – 7.0       5.4 – 10.0  

Expected volatility

     89 – 96     77 – 84

Risk-free interest rate

     2.0 – 2.3     1.3 – 1.9

Expected dividend rate

     —       —  
Summary of Stock-Based Compensation Activity

A summary of activity under the 2008 Plan and 2015 Plan and related information is as follows:

 

           Options Outstanding  
     Shares
Available
for Grant
    Number
of Shares
Outstanding
    Weighted-
Average
Exercise
Price Per
Share
     Weighted-
Average
Remaining
Contractual
Term
(Years)
     Aggregate
Intrinsic
Value of
Outstanding
Options
(in thousands)
 

Outstanding — December 31, 2016

     1,392,521       6,543,654     $ 3.44        8.82      $ 888  

Awards authorized

     1,214,837            

Options granted

     (1,206,775     1,206,775       1.47        

Options exercised

     —         (49,861     0.46        

Options forfeited/cancelled

     85,516       (85,516     4.64        
  

 

 

   

 

 

         

Outstanding — March 31, 2017

     1,486,099       7,615,052     $ 3.13        8.81      $ 972  
  

 

 

   

 

 

         

Exercisable — March 31, 2017

       3,085,928     $ 2.80        8.03      $ 899  
    

 

 

         

Vested and expected to vest — March 31, 2017

       7,615,052     $ 3.13        8.81      $ 972